Clinical Trials
6 trialsNCT00516724 2025-04-11
Study to Assess the Safety and Tolerability of a PARP Inhibitor in Combination With Carboplatin and/or Paclitaxel
AstraZeneca
Phase 1 Completed
NCT02658214 2020-08-20
Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors
AstraZeneca
Phase 1 Completed
NCT01314833 2020-05-19
Minus Anthracycline or Short-Term Versus Epirubicin and Cyclophosphamide Followed by Paclitaxel Regimen for Adjuvant Breast Cancer Therapy
Fudan University
Phase 3 Completed
NCT00689156 2018-04-05
READ
Danish Breast Cancer Cooperative Group
Phase 3 Completed
NCT00919880 2014-08-15
Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer
Peking University
Phase 2 Completed
NCT01203267 2010-09-16
Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer
Shanghai Jiao Tong University School of Medicine
Phase 2 Completed